Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS)
CNY 16.74
(-0.71%)
CNY 16.74
(-0.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 13.24 Billion | 14.95 Billion | 15.76 Billion | 16 Billion | 14.25 Billion | 13.66 Billion |
| Cost of Revenue | 4.54 Billion | 4.23 Billion | 4.13 Billion | 3.74 Billion | 2.38 Billion | 2.35 Billion |
| Gross Profit | 8.7 Billion | 10.71 Billion | 11.62 Billion | 12.26 Billion | 11.86 Billion | 11.31 Billion |
| Operating Expenses | 8.48 Billion | 8.8 Billion | 9.66 Billion | 9.79 Billion | 9.4 Billion | 8.99 Billion |
| Selling, General and Administrative Expenses | 7.37 Billion | 7.72 Billion | 8.56 Billion | 8.66 Billion | 8.42 Billion | 8.27 Billion |
| Research and Development Expenses | 476.5 Million | 284.12 Million | 408.6 Million | 533.41 Million | 505.36 Million | 480.23 Million |
| Other Expenses | 639.07 Million | 795.83 Million | 695.67 Million | 603.85 Million | 475.61 Million | -15.74 Million |
| Cost and Expenses | 12.8 Billion | 13.03 Billion | 13.79 Billion | 13.54 Billion | 11.79 Billion | 11.35 Billion |
| Operating Income | 436.01 Million | 1.92 Billion | 1.74 Billion | 2.36 Billion | 2.42 Billion | 2.27 Billion |
| Interest Expense | 109.93 Million | 135.09 Million | 167.28 Million | 145.04 Million | 136.77 Million | 91.62 Million |
| Income Tax Expense | 242.69 Million | 331.59 Million | 478.28 Million | 517.55 Million | 451.48 Million | 347.1 Million |
| Earnings before Tax | 394.55 Million | -1.38 Billion | 1.71 Billion | 2.36 Billion | 2.41 Billion | 2.25 Billion |
| Net Income | 318.97 Million | -1.71 Billion | 1.16 Billion | 1.86 Billion | 1.94 Billion | 1.88 Billion |
| Earnings Per Share Basic | 0.29 | -1.55 | 1.17 | 1.68 | 1.74 | 1.65 |
| Earnings Per Share Diluted | 0.29 | -1.55 | 1.17 | 1.68 | 1.74 | 1.65 |
| Weighted Average Shares Outstanding | 1.1 Billion | 1.1 Billion | 1.1 Billion | 1.1 Billion | 1.11 Billion | 1.14 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.1 Billion | 1.1 Billion | 1.1 Billion | 1.1 Billion | 1.11 Billion | 1.14 Billion |
| Gross Margin | 0.66 | 0.72 | 0.74 | 0.77 | 0.83 | 0.83 |
| EBIT Margin | 0.08 | 0.16 | 0.16 | 0.18 | 0.20 | 0.20 |
| Profit Margin | 0.02 | -0.11 | 0.07 | 0.12 | 0.14 | 0.14 |
| EBITDA | 1.09 Billion | -610.52 Million | 2.26 Billion | 2.92 Billion | 2.88 Billion | 2.65 Billion |
| Earnings Before Tax Margin | 0.03 | 0.13 | 0.11 | 0.15 | 0.17 | 0.17 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 3.08 Billion | 2.75 Billion | 2.59 Billion | 13.02 Billion | 3.2 Billion | 3.02 Billion |
| Cost of Revenue | 1.31 Billion | 1.32 Billion | 1.09 Billion | 4.54 Billion | 1.15 Billion | 949.98 Million |
| Gross Profit | 1.76 Billion | 1.43 Billion | 1.5 Billion | 8.48 Billion | 2.05 Billion | 2.07 Billion |
| Operating Expenses | 1.54 Billion | 1.21 Billion | 1.28 Billion | 7.43 Billion | 2.03 Billion | 1.81 Billion |
| Selling, General and Administrative Expenses | 1.89 Billion | 1.12 Billion | 1.24 Billion | - | 1.75 Billion | 2.05 Billion |
| Research and Development Expenses | 58.17 Million | 72.31 Million | 46.02 Million | - | 180.34 Million | 50.7 Million |
| Other Expenses | -416.15 Million | -22.16 Million | -127.87 Thousand | -43.37 Million | -100.94 Million | -26.68 Million |
| Cost and Expenses | 2.85 Billion | 2.54 Billion | 2.37 Billion | 11.97 Billion | 3.19 Billion | 2.76 Billion |
| Operating Income | 185.33 Million | 211.6 Million | 220.61 Million | 1.05 Billion | 15.86 Million | 243.2 Million |
| Interest Expense | 32.21 Million | 33.2 Million | 29.35 Million | 109.93 Million | 25.06 Million | 32.31 Million |
| Income Tax Expense | 61.13 Million | 100.13 Million | 122.7 Million | 242.69 Million | -6.87 Million | 68.86 Million |
| Earnings before Tax | 97.87 Million | 186.58 Million | 212.35 Million | 384.25 Million | -692.29 Million | 216.51 Million |
| Net Income | 81.44 Million | 117.4 Million | 114.01 Million | 318.97 Million | -606.17 Million | 179 Million |
| Earnings Per Share Basic | 0.08 | 0.11 | 0.10 | - | -0.55 | 0.16 |
| Earnings Per Share Diluted | 0.08 | 0.11 | 0.10 | - | -0.55 | 0.16 |
| Weighted Average Shares Outstanding | 1.07 Billion | 1.09 Billion | 1.1 Billion | 1.1 Billion | 1.1 Billion | 1.1 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.07 Billion | 1.09 Billion | 1.1 Billion | 1.1 Billion | 1.1 Billion | 1.1 Billion |
| Gross Margin | 0.57 | 0.52 | 0.58 | 0.65 | 0.64 | 0.69 |
| EBIT Margin | 0.04 | 0.13 | 0.08 | - | 0.05 | 0.08 |
| Profit Margin | 0.03 | 0.04 | 0.04 | 0.02 | -0.19 | 0.06 |
| EBITDA | 130.08 Million | 365.12 Million | 215.88 Million | - | 167.2 Million | 236.87 Million |
| Earnings Before Tax Margin | 0.06 | 0.08 | 0.08 | 0.08 | 0.00 | 0.08 |
AAUGF
CMRB
7038
IRS-WT
BAMBINO
NHCFOODS